PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-24.11%
G&A reduction while CRON.TO shows 4.56% growth. Joel Greenblatt would examine efficiency advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-24.11%
Operating expenses reduction while CRON.TO shows 11.36% growth. Joel Greenblatt would examine advantage.
-24.11%
Total costs reduction while CRON.TO shows 6.73% growth. Joel Greenblatt would examine advantage.
10.43%
Interest expense change of 10.43% while CRON.TO maintains costs. Bruce Berkowitz would investigate control.
No Data
No Data available this quarter, please select a different quarter.
24.11%
EBITDA growth 50-75% of CRON.TO's 47.71%. Martin Whitman would scrutinize operations.
No Data
No Data available this quarter, please select a different quarter.
24.11%
Operating income growth while CRON.TO declines. John Neff would investigate advantages.
No Data
No Data available this quarter, please select a different quarter.
10.43%
Other expenses growth while CRON.TO reduces costs. John Neff would investigate differences.
25.74%
Pre-tax income growth while CRON.TO declines. John Neff would investigate advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
25.74%
Net income growth while CRON.TO declines. John Neff would investigate advantages.
No Data
No Data available this quarter, please select a different quarter.
25.49%
EPS growth while CRON.TO declines. John Neff would investigate advantages.
25.49%
Diluted EPS growth while CRON.TO declines. John Neff would investigate advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.